NEW YORK (GenomeWeb News) – Bioinformatics company Cartagenia today announced it received a Canadian medical establishment license for its Cartagenia Bench platform.

The platform is a cloud-based software product for the analysis, interpretation, reporting, and sharing of genomic variants in routine clinical diagnostics. It is CE marked, registered with the US Food and Drug Administration as an exempt Class I Medical Device, and registered in Europe also as a Class I Medical Device, Cartagenia said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.